The confirmation on Monday, October 12, that Taylor Swift’s “Patient Zero” secured a second consecutive week atop the Billboard Hot 100 prompted a sharp repricing in prediction markets, with traders significantly increasing bets that the single will have a long-term stay at number one. On the Kalshi exchange, the contract for the song spending "At least 4 weeks" at No. 1 surged to 60% from just 1%, a 59-percentage-point jump. The move suggests traders view the song's ability to hold the top spot against new competition as a strong signal of chart durability.
This repricing represents a significant shift in expectations for the song's longevity. Before the second-week data was confirmed, the market implied only a negligible chance of a month-long reign. The current 60% probability indicates that a four-week run is now considered the most likely outcome by traders.
Distribution Analysis
The market, structured as a binary question of whether the song's run will last at least four weeks, saw a decisive shift from "No" to "Yes" following the news.
| Outcome | Current Prob | Change | Volume |
|---|---|---|---|
| At least 4 weeks | 60% | +59.0pp | 23 |
| Fewer than 4 weeks | 40% | -59.0pp | * |
* Volume on the declining contract is not reported but mirrors the rising contract in a binary market.
Net: The market repriced sharply toward a longer chart reign, shifting 59 percentage points of probability into the "At least 4 weeks" outcome.
What's Driving the Shift
The primary catalysts for the market's re-evaluation appear to be the song's proven staying power and historical precedent.
Confirmed Chart Durability: The key driver was the official Billboard report on October 12, confirming the song’s second week at No. 1 for the chart dated October 17. While many songs debut strong on fan-driven activity and then fall quickly, holding the top position demonstrates broader, sustained appeal. "Patient Zero" maintained its lead with 17.4 million streams, fending off a top-five debut from Drake and Don Toliver.
Historical Precedent: Taylor Swift has a well-established track record of multi-week hits. "Patient Zero" is her 10th single to spend two or more weeks at No. 1. This history of sustained chart dominance, including a 10-week run for 2025's "The Fate of Ophelia," gives traders a data-backed reason to believe "Patient Zero" could follow a similar trajectory.
Low Volume Caveat: While the percentage-point shift was dramatic, it occurred on relatively low trading volume (23 contracts). This indicates that while conviction among active traders is strong, the new 60% price may not yet reflect a deep market consensus and could be subject to further volatility as more participants weigh in.
Market Context
"Patient Zero" debuted at No. 1 by dethroning Ella Langley's "Choosin' Texas," which had an historic 24-week run at the top of the Hot 100. This established a competitive environment where sustained dominance is not guaranteed.
The song is one of four new tracks from The Life of a Showgirl: The Encore, the deluxe version of her 2025 album. Its second-week performance confirms its strength as a lead single, giving Swift her 51st total week at No. 1 across all her chart-topping songs, the fifth-most in history.
What to Watch
The market's direction will hinge on the next two Billboard Hot 100 chart announcements. Streaming, radio airplay, and sales figures for the tracking week ending October 15 (reported around October 19) will be critical. Traders will be watching to see if "Patient Zero" can maintain its lead over strong competitors and how quickly its own consumption metrics decay. The prediction market is scheduled to close on December 26, 2026, and will settle based on official chart data published by Billboard.
